This Article Full Text Full Text (PDF) All Versions of this Article: 36/12/2609    most recent 01.STR.0000190004.36793.2dv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tomitori, H. Articles by Igarashi, K. Search for Related Content PubMed PubMed Citation Articles by Tomitori, H. Articles by Igarashi, K. Related Collections Cerebrovascular disease/stroke CT and MRI Other diagnostic testing Risk Factors for Stroke

(Stroke. 2005;36:2609.)
© 2005 American Heart Association, Inc.

Original Contributions

Polyamine Oxidase and Acrolein as Novel Biochemical Markers for Diagnosis of Cerebral Stroke

Hideyuki Tomitori, PhD; Teruyoshi Usui; Naokatsu Saeki, MD, PhD; Shiro Ueda, MD, PhD; Hiroshi Kase, PhD; Kazuhiro Nishimura, PhD; Keiko Kashiwagi, PhD Kazuei Igarashi, PhD

From the Graduate School of Pharmaceutical Sciences (H.T., T.U., S.U., K.N., K.K., K.I.), Chiba University, Japan; Graduate School of Medicine (N.S.), Chiba University, Japan; and Fuence Co., Ltd. (H.T., H.K.), Shibuya-ku, Tokyo, Japan.

Correspondence to Kazuei Igarashi, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan. E-mail iga16077{at}p.chiba-u.ac.jp

Background and Purpose— We found previously that plasma levels of acrolein (CH₂=CHCHO) and spermine oxidase (SMO) were well correlated with the degree of severity of chronic renal failure. The aim of this study was to test whether the levels of these 2 markers and of acetylpolyamine oxidase (AcPAO) were increased in the plasma of stroke patients.

Methods— The activity of AcPAO and SMO and the level of protein-conjugated acrolein in plasma of the stroke patients and normal subjects were measured by high-performance liquid chromatography and ELISA, respectively. Focal infarcts were estimated by MRI or computed tomography (CT).

Results— The levels of AcPAO, SMO, and acrolein were significantly increased in the plasma of stroke patients. The size of stroke was nearly parallel with the multiplied value of acrolein and total polyamine oxidase (AcPAO plus SMO). After the onset of stroke, an increase in AcPAO first occurred, followed by increased levels of SMO and finally acrolein. In 1 case, an increase in AcPAO and SMO preceded focal damage as detected by MRI or CT. Furthermore, stroke was confirmed by MRI in a number of mildly symptomatic patients (11 cases) who had increased levels of total polyamine oxidase and acrolein. Among apparently normal subjects (8 cases) who had high values of acroleinxtotal polyamine oxidase, stroke was found in 4 cases by MRI.

Conclusions— The results indicate that increased levels of AcPAO, SMO, and acrolein are good markers of stroke.

Key Words: acrolein • polyamines • stroke

This article has been cited by other articles:

				R. Saiki, K. Nishimura, I. Ishii, T. Omura, S. Okuyama, K. Kashiwagi, and K. Igarashi Intense Correlation Between Brain Infarction and Protein-Conjugated Acrolein Stroke, October 1, 2009; 40(10): 3356 - 3361. [Abstract] [Full Text] [PDF]

				W. Whiteley, M.-C. Tseng, and P. Sandercock Blood Biomarkers in the Diagnosis of Ischemic Stroke: A Systematic Review Stroke, October 1, 2008; 39(10): 2902 - 2909. [Abstract] [Full Text] [PDF]